Skip to main content
Clinical Trials/ACTRN12605000481673
ACTRN12605000481673CompletedPhase 2

A double-blind randomised placebo controlled study to evaluate the effects of different doses of testosterone from a Testosterone Metered-Dose Transdermal Spray (MDTS) on sexual function in premenopausal women with low libido

FemPharm Pty Ltd and/or Acrux DDS Pty Ltd0 sites200 target enrollmentStarted: September 23, 2005Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
200

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to ot stated (—)
Sex
Female

Inclusion Criteria

  • Postmenopausal women suffering from low libido with low serum testosterone who are otherwise healthy.

Exclusion Criteria

  • No exclusion criteria

Investigators

Sponsor
FemPharm Pty Ltd and/or Acrux DDS Pty Ltd

Similar Trials

A double-blind randomised placebo... | Clinical Trial